Seminars in Thoracic and Cardiovascular Surgery
Volume 19, Issue 3 , Pages 228-237 , Autumn 2007

The Molecular Basis of Congenital Heart Disease

  • Michael E. Mitchell, MD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Children’s Hospital of Wisconsin, and Children’s Research Institute, Milwaukee, Wisconsin.
    • Corresponding Author InformationAddress reprint requests to Michael E. Mitchell, MD, Department of Surgery, Children’s Hospital of Wisconsin, Medical College of Wisconsin, 9000 W. Wisconsin Ave, MS 715, Milwaukee, WI 53226.
    • ,
  • Tara L. Sander, PhD

      Affiliations

    • Department of Surgery, Division of Pediatric Surgery, Medical College of Wisconsin and Children’s Research Institute, Milwaukee, Wisconsin.
    • ,
  • Denise B. Klinkner, MD

      Affiliations

    • Department of General Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.
    • ,
  • Aoy Tomita-Mitchell, PhD

      Affiliations

    • Department of Surgery, Division of Cardiothoracic Surgery, Medical College of Wisconsin, Children’s Research Institute, Biotechnology and Bioengineering Center, and Human and Molecular Genetics Center, Milwaukee, Wisconsin.

References 

  1. Hoffman JI. Incidence of congenital heart disease: I (Postnatal incidence). Pediatr Cardiol. 1995;16:103–113
  2. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol. 2002;39:1890–1900
  3. Srivastava D. Making or breaking the heart: from lineage determination to morphogenesis. Cell. 2006;126:1037–1048
  4. Gittenberger-de Groot AC, Bartelings MM, Deruiter MC, et al. Basics of cardiac development for the understanding of congenital heart malformations. Pediatr Res. 2005;57:169–176
  5. McFadden DG, Olson EN. Heart development: learning from mistakes. Curr Opin Genet Dev. 2002;12:328–335
  6. Fishman MC, Chien KR. Fashioning the vertebrate heart: earliest embryonic decisions. Development. 1997;124:2099–2117
  7. Srivastava D, Olson EN. A genetic blueprint for cardiac development. Nature. 2000;407:221–226
  8. Bernanke DH, Velkey JM. Development of the coronary blood supply: changing concepts and current ideas. Anat Rec. 2002;269:198–208
  9. Allan LD, Sharland G, Tynan MJ. The natural history of the hypoplastic left heart syndrome. Int J Cardiol. 1989;25:341–343
  10. Garry DJ, Olson EN. A common progenitor at the heart of development. Cell. 2006;127:1101–1104
  11. Munoz-Chapuli R, Macias D, Gonzalez-Iriarte M, et al. [The epicardium and epicardial-derived cells: multiple functions in cardiac development.]. Rev Esp Cardiol. 2002;55:1070–1082
  12. Hatcher CJ, Diman NY, Kim MS, et al. A role for Tbx5 in proepicardial cell migration during cardiogenesis. Physiol Genomics. 2004;18:129–140
  13. Landerholm TE, Dong XR, Lu J, et al. A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development. 1999;126:2053–2062
  14. Nelson TJ, Duncan SA, Misra RP. Conserved enhancer in the serum response factor promoter controls expression during early coronary vasculogenesis. Circ Res. 2004;94:1059–1066
  15. Carmona R, Gonzalez-Iriarte M, Perez-Pomares JM, et al. Localization of the Wilm’s tumour protein WT1 in avian embryos. Cell Tissue Res. 2001;303:173–186
  16. Eisenberg LM, Markwald RR. Cellular recruitment and the development of the myocardium. Dev Biol. 2004;274:225–232
  17. Sieber-Blum M. Cardiac neural crest stem cells. Anat Rec A Discov Mol Cell Evol Biol. 2004;276:34–42
  18. Stoller JZ, Epstein JA. Cardiac neural crest. Semin Cell Dev Biol. 2005;16:704–715
  19. Armstrong EJ, Bischoff J. Heart valve development: endothelial cell signaling and differentiation. Circ Res. 2004;95:459–470
  20. Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287–335
  21. Mjaatvedt CH, Yamamurs H, Wessels A, et al. Mechanisms of segmentation, septation, and remodeling of the tubular heart: Endocardial cushion fate and cardiac looping. In:  Harvey RP,  Rosenthal N editor. Heart Development. San Diego: Academic Press; 1999;p. 159–177
  22. Ramsdell AF, Markwald RR. Induction of endocardial cushion tissue in the avian heart is regulated, in part, by TGFbeta-3-mediated autocrine signaling. Dev Biol. 1997;188:64–74
  23. Brown CB, Boyer AS, Runyan RB, et al. Requirement of type III TGF-beta receptor for endocardial cell transformation in the heart. Science. 1999;283:2080–2082
  24. Chen B, Bronson RT, Klaman LD, et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis. Nat Genet. 2000;24:296–299
  25. Galvin KM, Donovan MJ, Lynch CA, et al. A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet. 2000;24:171–174
  26. Lakkis MM, Epstein JA. Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development. 1998;125:4359–4367
  27. Bourdeau A, Dumont DJ, Letarte M. A murine model of hereditary hemorrhagic telangiectasia. J Clin Invest. 1999;104:1343–1351
  28. Camenisch TD, Spicer AP, Brehm-Gibson T, et al. Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme. J Clin Invest. 2000;106:349–360
  29. de la Pompa JL, Timmerman LA, Takimoto H, et al. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 1998;392:182–186
  30. Gruber PJ, Kubalak SW, Pexieder T, et al. RXR alpha deficiency confers genetic susceptibility for aortic sac, conotruncal, atrioventricular cushion, and ventricular muscle defects in mice. J Clin Invest. 1996;98:1332–1343
  31. Ranger AM, Grusby MJ, Hodge MR, et al. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 1998;392:186–190
  32. Schilham MW, Oosterwegel MA, Moerer P, et al. Defects in cardiac outflow tract formation and pro-B-lymphocyte expansion in mice lacking Sox-4. Nature. 1996;380:711–714
  33. Ferencz C, Correa-Villasenor A, Loffredo CA, et al. Malformations of the cardiac outflow tract. In:  Ferencz C,  Loffredo CA,  Correa-Villasenor A, et al. editor. Genetic and Environmental Risk Factors of Major Cardiovascular Malformations: The Baltimore-Washington Infant Study: 1981-1989 (No. 5, Anderson RH, series editor). Armonk: Futura Publishing Company, Inc; 1997;p. 59–102
  34. Ferencz C, Rubin JD, Loffredo CA, et al. Epidemiology of Congenital Heart Disease: the Baltimore-Washington Infant Study, 1981-1989. 1993;
  35. Loffredo CA. Epidemiology of cardiovascular malformations: prevalence and risk factors. Am J Med Genet. 2000;97:319–325
  36. Loffredo CA, Silbergeld EK, Ferencz C, et al. Association of transposition of the great arteries in infants with maternal exposures to herbicides and rodenticides. Am J Epidemiol. 2001;153:529–536
  37. Loffredo CA, Wilson PD, Ferencz C. Maternal diabetes: an independent risk factor for major cardiovascular malformations with increased mortality of affected infants. Teratology. 2001;64:98–106
  38. Nora JJ, Nora AH. Recurrence risks in children having one parent with a congenital heart disease. Circulation. 1976;53:701–702
  39. McElhinney DB, Geiger E, Blinder J, et al. NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol. 2003;42:1650–1655
  40. Lints TJ, Parsons LM, Hartley L, et al. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. [published erratum appears in Development 119:969, 1993] Development. 1993;119:419–431
  41. Lyons I, Parsons LM, Hartley L, et al. Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev. 1995;9:1654–1666
  42. Tanaka M, Chen Z, Bartunkova S, et al. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development. 1999;126:1269–1280
  43. Benson DW, Silberbach GM, Kavanaugh-McHugh A, et al. Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest. 1999;104:1567–1573
  44. Schott JJ, Benson DW, Basson CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science. 1998;281:108–111
  45. Goldmuntz E, Geiger E, Benson DW. NKX2.5 mutations in patients with tetralogy of fallot. Circulation. 2001;104:2565–2568
  46. Davis DL, Wessels A, Burch JB. An Nkx-dependent enhancer regulates cGATA-6 gene expression during early stages of heart development. Dev Biol. 2000;217:310–322
  47. Jiang Y, Drysdale TA, Evans T. A role for GATA-4/5/6 in the regulation of Nkx2.5 expression with implications for patterning of the precardiac field. Dev Biol. 1999;216:57–71
  48. Molkentin JD, Antos C, Mercer B, et al. Direct activation of a GATA6 cardiac enhancer by Nkx2.5: evidence for a reinforcing regulatory network of Nkx2.5 and GATA transcription factors in the developing heart. Dev Biol. 2000;217:301–309
  49. Horb ME, Thomsen GH. Tbx5 is essential for heart development. Development. 1999;126:1739–1751
  50. Liberatore CM, Searcy-Schrick RD, Yutzey KE. Ventricular expression of tbx5 inhibits normal heart chamber development. Dev Biol. 2000;223:169–180
  51. Basson CT, Bachinsky DR, Lin RC, et al. Mutations in human TBX5 [corrected] cause limb and cardiac malformation in Holt-Oram syndrome. Nat Genet. 1997;15:30–35
  52. Li QY, Newbury-Ecob RA, Terrett JA, et al. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet. 1997;15:21–29
  53. Habets PE, Moorman AF, Clout DE, et al. Cooperative action of Tbx2 and Nkx2.5 inhibits ANF expression in the atrioventricular canal: implications for cardiac chamber formation. Genes Dev. 2002;16:1234–1246
  54. Hiroi Y, Kudoh S, Monzen K, et al. Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation. Nat Genet. 2001;28:276–280
  55. Parmacek MS, Leiden JM. GATA transcription factors and cardiac development. In:  Harvey RP,  Rosenthal N editor. Heart Development. San Diego: Academic Press; 1999;p. 291–306
  56. Shiojima I, Komuro I, Oka T, et al. Context-dependent transcriptional cooperation mediated by cardiac transcription factors Csx/Nkx-2.5 and GATA-4. J Biol Chem. 1999;274:8231–8239
  57. Garg V, Kathiriya IS, Barnes R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature. 2003;424:443–447
  58. Okubo A, Miyoshi O, Baba K, et al. A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet. 2004;41:e97
  59. Rajagopal SK, Ma Q, Obler D, et al. Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol. 2007;June 21 (Epub ahead of print)
  60. Krantz ID, Smith R, Colliton RP, et al. Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet. 1999;84:56–60
  61. Warthen DM, Moore EC, Kamath BM, et al. Jagged1 (JAG1) mutations in Alagille syndrome: increasing the mutation detection rate. Hum Mutat. 2006;27:436–443
  62. Kadesch T. Notch signaling: a dance of proteins changing partners. Exp Cell Res. 2000;260:1–8
  63. Morrissette JD, Colliton RP, Spinner NB. Defective intracellular transport and processing of JAG1 missense mutations in Alagille syndrome. Hum Mol Genet. 2001;10:405–413
  64. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH1 cause aortic valve disease. Nature. 2005;437:270–274
  65. Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell. 2002;109(suppl):S67–S79
  66. Schulz RA, Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol. 2004;266:1–16
  67. Armesilla AL, Lorenzo E, Gomez del Arco P, et al. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol Cell Biol. 1999;19:2032–2043
  68. Hernandez GL, Volpert OV, Iniguez MA, et al. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J Exp Med. 2001;193:607–620
  69. Nolan GP. Cardiac development (Transcription and the broken heart). Nature. 1998;392:129–130
  70. Uhlen P, Burch PM, Zito CI, et al. Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling. Proc Natl Acad Sci U S A. 2006;103:2160–2165
  71. Vannay A, Vasarhelyi B, Kornyei M, et al. Single-nucleotide polymorphisms of VEGF gene are associated with risk of congenital valvuloseptal heart defects. Am Heart J. 2006;151:878–881
  72. Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–367
  73. Bokenkamp R, Gittenberger-De Groot AC, Van Munsteren CJ, et al. Persistent ductus arteriosus in the Brown-Norway inbred rat strain. Pediatr Res. 2006;60:407–412
  74. Wang WY, Barratt BJ, Clayton DG, et al. Genome-wide association studies: theoretical and practical concerns. Nat Rev Genet. 2005;6:109–118
  75. Pritchard JK. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet. 2001;69:124–137
  76. Tabor HK, Risch NJ, Myers RM. Opinion: Candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet. 2002;3:391–397
  77. Li-Sucholeiki XC, Hu G, Perls T, et al. Scanning the beta-globin gene for mutations in large populations by denaturing capillary and gel electrophoresis. Electrophoresis. 2005;26:2531–2538
  78. Li-Sucholeiki XC, Tomita-Mitchell A, Arnold K, et al. Detection and frequency estimation of rare variants in pools of genomic DNA from large populations using mutational spectrometry. Mutat Res. 2005;570:267–280
  79. Sharma HS, Peters TH, Moorhouse MJ, et al. DNA microarray analysis for human congenital heart disease. Cell Biochem Biophys. 2006;44:1–9
  80. Black DL. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem. 2003;72:291–336
  81. Clark TA, Schweitzer AC, Chen TX, et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol. 2007;8:R64
  82. Chuang JC, Jones PA. Epigenetics and MicroRNAs. Pediatr Res. 2007;61:24R–29R
  83. Zhao Y, Ransom JF, Li A, et al. Dysregulation of cardiogenesis (cardiac conduction, and cell cycle in mice lacking miRNA-1-2). Cell. 2007;129:303–317
  84. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428
  85. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer—a mechanism for early oncogenic pathway addiction?. Nat Rev Cancer. 2006;6:107–116
  86. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003;33(suppl):245–254
  87. Sarkozy A, Conti E, Neri C, et al. Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet. 2005;42:e16
  88. Zhu L, Vranckx R, Khau Van Kien P, et al. Mutations in myosin heavy chain 11 cause a syndrome associating thoracic aortic aneurysm/aortic dissection and patent ductus arteriosus. Nat Genet. 2006;38:343–349
  89. Elliott DA, Kirk EP, Yeoh T, et al. Cardiac homeobox gene NKX2-5 mutations and congenital heart disease: associations with atrial septal defect and hypoplastic left heart syndrome. J Am Coll Cardiol. 2003;41:2072–2076
  90. Hatcher CJ, Basson CT. Getting the T-box dose right. Nat Med. 2001;7:1185–1186
  91. Ching YH, Ghosh TK, Cross SJ, et al. Mutation in myosin heavy chain 6 causes atrial septal defect. Nat Genet. 2005;37:423–428
  92. Robinson SW, Morris CD, Goldmuntz E, et al. Missense mutations in CRELD1 are associated with cardiac atrioventricular septal defects. Am J Hum Genet. 2003;72:1047–1052
  93. Eldadah ZA, Hamosh A, Biery NJ, et al. Familial tetralogy of Fallot caused by mutation in the jagged1 gene. Hum Mol Genet. 2001;10:163–169
  94. Bamford RN, Roessler E, Burdine RD, et al. Loss-of-function mutations in the EGF-CFC gene CFC1 are associated with human left-right laterality defects. Nat Genet. 2000;26:365–369
  95. Ware SM, Peng J, Zhu L, et al. Identification and functional analysis of ZIC3 mutations in heterotaxy and related congenital heart defects. Am J Hum Genet. 2004;74:93–105
  96. Heritage ML, MacMillan JC, Colliton RP, et al. Jagged1 (JAG1) mutation detection in an Australian Alagille syndrome population. Hum Mutat. 2000;16:408–416
  97. Satoda M, Zhao F, Diaz GA, et al. Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus. Nat Genet. 2000;25:42–46
  98. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004;89:148–151
  99. Yagi H, Furutani Y, Hamada H, et al. Role of TBX1 in human del22q11.2 syndrome. Lancet. 2003;362:1366–1373
  100. Vaughan CJ, Basson CT. Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus. Am J Med Genet. 2000;97:304–309
  101. Grossfeld PD, Mattina T, Lai Z, et al. The 11q terminal deletion disorder: a prospective study of 110 cases. Am J Med Genet A. 2004;129:51–61
  102. Tartaglia M, Gelb BD. Noonan syndrome and related disorders: genetics and pathogenesis. Annu Rev Genomics Hum Genet. 2005;6:45–68
  103. Stromme P, Bjornstad PG, Ramstad K. Prevalence estimation of Williams syndrome. J Child Neurol. 2002;17:269–271
  104. Goldstein H, Nielsen KG. Rates and survival of individuals with trisomy 13 and 18 (Data from a 10-year period in Denmark). Clin Genet. 1988;34:366–372
  105. Bishop J, Huether CA, Torfs C, et al. Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991. Am J Epidemiol. 1997;145:134–147
  106. Eronen M, Peippo M, Hiippala A, et al. Cardiovascular manifestations in 75 patients with Williams syndrome. J Med Genet. 2002;39:554–558
  107. Sander TL, Klinkner DB, Tomita-Mitchell A, et al. Molecular and cellular basis of congenital heart disease. Pediatr Clin North Am. 2006;53:989–1009

 Supported in part by an award from the Children’s Hospital of Wisconsin Research Foundation and Children’s Research Institute, Milwaukee, Wisconsin (T.L.S., A.T.-M.) and by grant # P20-RR/DE17702 (A.T.-M.) from the National Center for Research Resources, a component of the National Institutes of Health.

PII: S1043-0679(07)00122-0

doi: 10.1053/j.semtcvs.2007.07.013

Seminars in Thoracic and Cardiovascular Surgery
Volume 19, Issue 3 , Pages 228-237 , Autumn 2007

Article Tools

* Image Usage & Resolution